Clock Mutant Promotes Osteoarthritis by Inhibiting the Acetylation of NFκB.

G. Yuan,L. Xu,T. Cai,B. Hua,N. Sun,Z. Yan,C. Lu,R. Qian
DOI: https://doi.org/10.1016/j.joca.2019.01.012
IF: 7.507
2019-01-01
Osteoarthritis and Cartilage
Abstract:Objectives: To examine the effect of the circadian gene Clock on posttranscriptional function and pro-inflammatory mechanisms in osteoarthritis (OA). Methods: The cartilage from Clock mutant mice was assessed using histology, (OA) score, and real-time polymerase chain reaction (PCR) quantification of key pro-inflammatory genes. Nuclear factor kappa-light-chain-enhancer of activated B cells (NF kappa B) translocation, posttranslational state and expression levels during day and night conditions were assessed using immunoblot and IP. The regulation of transcription by Clock in cartilage tissue was assessed by using chromatin immunoprecipitation (ChIP) and luciferase assays. Total acetylation level and pattern over 24 h were quantified using immunoblot and real-time PCR. Finally, the effects of exogenous Clock nanoparticle treatment were quantified by histology and immunoblot. Results: The Clock mutation significantly promoted the degradation of cartilage and the expression of the key pro-inflammatory mediators, IL-1b, IL-6 and MCP-1. The Clock mutation significantly promoted NF kappa B nuclear translocation. The circadian protein CLOCK positively regulates NF kappa B at the transcriptional level by binding the E-box domain. The Clock mutation significantly inhibited the total lysine acetylation level in cartilage and inhibited NF kappa B acetylation at the Lys310 residue but promoted phosphorylation at the Ser276 residue. The forced expression of Clock in vivo inhibited NF kappa B activation by increasing acetylation and decreasing phosphorylation levels and by decreasing cartilage damage and inflammation. Conclusions: This study demonstrates the mutation of Clock promotes inflammatory activity by mediating the posttranscriptional regulation of NF kappa B in OA pathogenesis. (C) 2019 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
What problem does this paper attempt to address?